Juxta-articular myxoma (JAM) is a very rare myxoid tumor in pediatric age. JAM is frequently located at large joints, particularly in the knee, and most lesions present as palpable swelling sometimes associated with pain or tenderness. Only three cases of pediatric JAM have been reported in the literature to date. We describe a case of JAM in a 12-year-old boy, characterized by several unique aspects related to age, site of onset, size, and associated symptoms.
J uxta-articular myxoma (JAM) is an uncommon benign tumor occurring between third and fifth decade of life. 1 The tumor is located most frequently at large joints (knee in 88% of cases). 2 Only three cases of pediatric JAM have been reported in the literature to date.
We present a case of JAM of the hip in a 12-year-old boy with several unique aspects.
Case Report
A 12-year-old boy was admitted because of the sudden appearance and increase in size in few days of a large swelling of the right buttock without functional limitations of the hip. The child was in good health and denied any recent trauma. Physical examination showed a right buttock lesion with a tight, but not painful, flexible consistency; superficial venous prominence or discoloration of the skin was absent. The range of motion of the hip was complete for both active and passive movements and free from pain. The patient had no lameness nor any painful symptoms in performing daily activities. Biochemical inves-tigations including complete blood count, liver and kidney function, inflammatory markers, and electrolytes were normal. No bone involvement at right hip radiograph. Ultrasonography showed, in comparison with another done before admittance, a complex mass with solid and cystic components increased in size of about 5 cm in 3 days. At lower-limb contrast MRI, evidence of an oval lesion, measuring 10 · 15 · 8 cm, located between the gluteus medius and the gluteus maximus. The lesion was well-capsulated, with branches and septa inside, weak endostructural diffusion, and wall irregularities with no infiltrative phenomena into surrounding tissues ( Figure 1 ). Total-body scintigraphy showed no metabolic activity at the level of the lesion.
An open incisional biopsy was done: histopathological analysis documented strands of fibrous tissue, with scattered lymphohistocytic infiltrate, as found in a chronically inflamed articular bursa ( Figure 2 ). In consideration of this diagnosis, the child was prescribed rest and nonsteroidal antiinflammatory therapy. Since failure of conservative treatment (no reduction of the mass), 2 months later, we proceeded to excision of the lesion.
The resected tumor measured 10 · 17 · 8 cm, was capsulated, and showed a mucoid multinodular appearance on cut section (Figure 1) . At pathological examination, the lesion consisted of variously sized, thick-walled cystic spaces; at high magnification, the lesion was composed of scattered, small, oval to spindle fibroblast-like cells embedded in a richly myxoid matrix, without cytologic atypia. The final diagnosis was JAM ( Figure 2 ).
The postoperative course was uneventful. Five years after surgery, the patient results free from relapse.
Discussion
JAM is an unusual benign lesion occurring between third and fifth decade of life 1,2 belonging to myxoid tumors, lesions characterized by abundant myxoid stroma and poor cellularity and intralesional vascularization. Histologically, JAM shows an abnormal accumulation of mucinous stroma and cellularity composed almost exclusively of mesenchymal cells. Regarding management and prognosis, to distinguish JAM from other benign and malignant entities is essential. 3 Complete surgical excision is the mainstay of treatment because local recurrence rate is estimated on 34%. 1, 4 The main differential diagnoses include intramuscular myxoma, myxoid malignant fibrous histiocytoma (myxofibrosarcoma), low-grade fibromyxoid sarcoma, myxoid liposarcoma, and ganglion cyst, of which characteristics are resumed in Table 1 .
In adults, the most frequent JAM localization is the knee (88% of cases), 2 followed by the elbow and shoulder, rarely ankle and wrist, and less frequently hip. Causes of JAM remain controversial, although the most credible hypothesis is post- traumatic or postarthritis disease. 10 In some cases, the pain was present even with no clinically detectable lesions, while in some others, swelling without pain was present.
JAM is a very rare tumor in children with only three pediatric cases described in the literature; in two cases, the tumor was located in the knee 2 and one in the wrist ( Table 2 ). JAM has never been reported as hip tumor in a pediatric patient. The presence of pain could help the differential diagnosis, even if children may have difficulty to locate the site of the pain, and sometimes, pain referred to hip could underlie knee or foot disease. Differential diagnosis of JAM involving the hip includes pigmented villonodular synovitis, hemophilia, nonspecific synovitis, juvenile idiopathic arthritis, synovial (osteo)chondromatosis, lipoma arborescens, and synovial hemangioma. 13 Other pathologies that could involve a hip joint are slipped femoral epiphysis, Several findings of our patient are similar to the other reported pediatric cases as like as medical history negative for both inflammatory diseases and trauma. Our patient was completely asymptomatic: In one of the two previously reported pediatric cases, the tumor was found in the knee without evidence of pain, while in the other two cases, the children presented with a painful mass. 2, 11, 12 A peculiar observation in our case was the dimensional discrepancy between the preoperative imaging and the excised mass, 2 cm bigger than expected. These data may indicate a rapid lesion growth, as previously described, 2, 11 or compression effect caused by surrounding tissues, which may have led us to underestimate the size based on the MRI scan.
In our case, as like as in previously reported 5-year-old boy case, biopsy was inefficacious because of collection of nonrepresentative tissue. Recently, Agrawal et al 14 reported fine needle aspiration citology of pediatric softtissue lesions and neoplasms as a firstline investigation. Anyway, in his study, histopathology provided more accurate subtyping than fine needle aspiration in 8/25 cases, all benign diagnoses as myxoma and lipoblastoma. We believe that even incisional biopsy can be misleading, thereby, delaying a correct diagnosis, while to differentiate JAM from other malignant entities is mandatory, and this could guide to a more aggressive approach. Surely, this point requires a higher debate.
Wide consensus about high recurrence of myxoid tumors in case of incomplete resection is found, and postoperative follow-up is important to detect relapse. As recurrence usually occurs within 18 months, 1 a minimum period of 2-year followup should be considered.
Conclusion
Management of children with JAM requires a multidisciplinary approach and long-term postoperative followup. In case of hip tumefaction without pain, JAM could be considered for a diagnosis, and a malignant entity should be excluded. Adequate treatment requires surgical removal of the entire mass. Preoperative biopsies seem to be misleading for diagnosis in the pediatric age group.
